Engineering, expression and renaturation of targeted TGF-beta fusion proteins

Connective Tissue Research

Volumn 34, Issue 1, 1996, Pages 1-9

  Tuan, Tai Lan ^a   Cheung, David T ^a   Wu, Ling Tao ^a   Yee, Ann ^a   Gabriel, Steven ^a   Han, Bo ^a   Morton, Lisa ^a   Nimni, Marcel E ^a,b   Hall, Frederick L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

collagen; expression; growth factors; purification; Recombinant TGF fusion protein; renaturation

Indexed keywords

ANIMALIA;

EID: 0030514339     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.3109/03008209609028888     Document Type: Article

References (37)

1. Ignotz, R.A., Massague, J. (1986). Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:4437-4448.
2. Heino, J., Ignotz, R.A., Hemler, M.E., Crouse, C., Massague, J. (1989). Regulation of cell adhesion receptors by transforming growth factor-beta. J. Biol. Chem. 264:380-388.
3. Ignotz, R.A., Heino, J., Massague, J. (1989). Regulation of cell adhesion receptors by transforming growth factor-beta. J. Biol. Chem. 264:389-392.
4. Laiho, M., Saksela, O., Keski-Oja, J. (1986). Transforming growth factor beta alters plasminogen activator activities in human skin fibroblasts. Exp. Cell Res. 164:399-407.
5. Keski-Oja, J., Raghow, R., Sawdey, M., Loskutoff, D.J., Postlethwaite, A.E., Kang, A., Moses, H.L. (1988). Regulation of RNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor beta. J. Biol. Chem. 263:3111-3115.
6. 1 in human A549 lung carcinoma cells. EMBO J. 10:3399-3407.
7. Roberts, A.B., Sporn, M.B. (1993). Physiological actions and clinical applications of transforming growth factor-beta (TGF-β). Growth Factors 8:1-9.
8. 2 for the treatment of full thickness macular holes. Ophthalmology 99:1162-1173.
9. Noda, M., Camilliere, J.J. (1989). In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124:2991-2994.
10. Joyce, M.E., Roberts, A.B., Sporn, M.B., Bolander, M.E. (1990). Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in rat femur. J. Cell Biol. 110:2195-2207.
11. Sporn, M.B., Roberts, A.B. (1989). Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA 262:938-941.
12. Bock, G., Marsh, J. (1991). Clinical application of TGF-beta. Ciba Found. Symp. 157, John Wiley and Sons, New York.
13. 1 reverses age- or glucocorticoid-impaired wound healing. J. Clin. Invest. 92:2841-2849.
14. Assoian, R.K., Sporn, M.B. (1986). Type-beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 102:1217-1223.
15. Cantrella, M. Canalis, E. (1985). Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. Pro. Natl. Acad. Sci. USA 82:7335-7339.
16. Frolik, C.A., Dart, L.L., Meyers, C.A., Smith, D.M., Sporn, M.B. (1983). Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA 80:3676-3680.
17. Roberts, A.B., Anzano, M.A., Meyers, C.A., Wideman, J., Blacher, R., Pan, Y.-C., Stein, S., Lehrman, S.R., Smithe, J.M., Lamb, L.C., Sporn, M.B. (1983). Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry 22:5692-5698.
18. Bourdrel, L., Lin, C.H., Lauren, S.L., Elmore, R.H. (1993). Recombinant human transforming growth factor-beta1: expression by chinese hamster ovary cells, isolation, and characterization. Protein Expression and Purification 4:130-140.
19. Anscher, M.S., Peters, W.P., Reisenbichler, H. Petros, W.P., Jirtle, R.L. (1993). Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. Eng. J. Med. 328:1592-1598.
20. Isaka, Y., Fujiwara, Y., Ueda, N., Kameda, Y., Kamada, T., Imai, E. (1993). Glomerulaosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92:2597-2601.
21. Khslil, N., Ehiymsn, V., Xuo, L., Danielpour, D., Greenberg, A. (1993). Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-incuced pulmonary inflammation in the rat. J. Clin. Invest. 92:1812-1818.
22. Flaumenhaft, R. Kojima, S., Abe, M., Rifkin, D. (1993). Activation of latent transforming growth factor β. Adv. in Pharmacology 24:51-76.
23. Flaumenhaft, R., Abe, M., Miyazono,K., Harpel, J.G., Heldin, C.H., Rifkin, D.B. (1993). Role of the latent TGF-β binding protein in the activation of latent TGF-beta co-culture of endothelial and smooth muscle cells. J. Cell Biol. 120:995-1002.
24. Schultz, C.S., Lawler, J., Murphy, U.J. (1994). The type I repeats of thrombospondin I activate latent transforming growth factor-β. J. Biol. Chem. 269:26783-26788.
25. Butzow, R., Fukushima, D., Twardzik, D.R., Ruoslahti, E. (1993). A 60-kD protein mediates the binding of transforming growth factor-β to cell surface and extracellular matrix proteoglycans. J. Cell Biol. 122:721-727.
26. Takagi, J., Jujisawa, T., Sekiya, F., Saito, Y. (1991). Collagen binding domain within bovine propolypeptide of von Willebrand factor. J. Biol. Chem. 256:5575-79.
27. Takagi, J., Asai, H., Saito, Y. (1992). A collagen/gelatin-binding decapeptide derived from bovine propolypeptide of von Willebrand factor. Biochem. 31:8530-8534.
28. Derynck, R., Jarrett, J.A., Chen, E.Y., Eaton, D.H., Bell, J.R., Assoian, R.K., Roberts, A.B., Sporn, M.B., Goeddel, D.V. (1985). Human transforming growth factor beta cDNA sequence and expression in tumor cell lines. Nature 316:701-705.
29. Chang, J., Swartz, J.R. (1993). "Single-step solubilization and folding of IGF-1 aggregates from Escherichia coli." In: Protein Folding In Vivo and in Vitro, edited by J.L. Cleland, Symposium Series 526:178-188, American Chemical Society, Washington DC.
30. Glocker, M.O., Arbogast, B., Milley, R., Cowgill, C., Deinzer, M.L. (1994). Disulfide linkages in the in vitro refolded intermediates of recombinant human macrophage-colony-stimulating factor: Analysis of the sulfhydryl alkylation of free systeine residues by fast-atom bombardment mass spectrometry. J. Biol. Chem. 91:5868-5872.
31. Ikeda, T., Lioubin, M.N., Marquardt, H. (1987). Human transforming growth factor type B2 production by a prosthetic adenocarcinoma cell line, purification and initial characterization. Biochemistry 26:2406-2410.
32. 2. Nature 358:430-434.
33. Roberts, A.B., Sporn, M.B. (1990). "The transforming growth factor betas." In: Peptide Growth Factors and Their Receptors. Hand book of Experimental Pharmacology, edited by A. B. Roberts and M. B. Sporn, 419-471, Springer-Verlag, Heidelberg.
34. Sampath, T.K., Reddi, A.H. (1981). Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Nat. Acad. Sci. 78:7599-7603.
35. Strates, B.S., Urist, M.R. (1969). Origin of the inductive signal in implants of normal and lathyritic bone matrix. Clin. Ortho. and Rel. Res. 66:226-240.
36. 1, associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell Biol. 124:171-181.
37. 1 pro-regions in homodimer assembly. Science 247:1328-1330.